BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3676511)

  • 1. Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study.
    Blood; 1987 Dec; 70(6):1718-21. PubMed ID: 3676511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative incidence of agranulocytosis and aplastic anemia.
    Kaufman DW; Kelly JP; Issaragrisil S; Laporte JR; Anderson T; Levy M; Shapiro S; Young NS
    Am J Hematol; 2006 Jan; 81(1):65-7. PubMed ID: 16369972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of aplastic anemia and agranulocytosis in Latin America--the LATIN study.
    Hamerschlak N; Maluf E; Pasquini R; Eluf-Neto J; Moreira FR; Cavalcanti AB; Okano IR; Falcão RP; Pita MT; Loggetto SR; Rosenfeld LG; Lorand-Metze IG
    Sao Paulo Med J; 2005 May; 123(3):101-4. PubMed ID: 16021270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agranulocytosis and aplastic anemia among Ramathibodi Hospital patients.
    Jootar S; Chaisiripoomkere W; Rojanasthien S
    J Med Assoc Thai; 1992 Sep; 75(9):514-6. PubMed ID: 1304020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
    JAMA; 1986 Oct; 256(13):1749-57. PubMed ID: 3747087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional patterns in the incidence of aplastic anemia in Thailand. The Aplastic Anemia Study Group.
    Issaragrisil S; Leaverton PE; Chansung K; Thamprasit T; Porapakham Y; Vannasaeng S; Piankijagum A; Kaufman DW; Anderson TE; Shapiro S; Young NS
    Am J Hematol; 1999 Jul; 61(3):164-8. PubMed ID: 10398308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient pancytopenia. A report from the International Agranulocytosis and Aplastic Study.
    Keisu M; Heit W; Lambertenghi-Deliliers G; Parcells-Kelly J; Polliack A; Heimpel H
    Blut; 1990 Oct; 61(4):240-4. PubMed ID: 2224146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia.
    Böttiger LE; Böttiger B
    Acta Med Scand; 1981; 210(6):475-9. PubMed ID: 7331894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study.
    Maluf E; Hamerschlak N; Cavalcanti AB; Júnior AA; Eluf-Neto J; Falcão RP; Lorand-Metze IG; Goldenberg D; Santana CL; Rodrigues Dde O; Passos LN; Rosenfeld LG; Pitta M; Loggetto S; Ribeiro AA; Velloso ED; Kondo AT; Coelho EO; Pintão MC; de Souza HM; Borbolla JR; Pasquini R
    Haematologica; 2009 Sep; 94(9):1220-6. PubMed ID: 19734415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.
    Kelly JP; Kaufman DW; Shapiro S
    Clin Pharmacol Ther; 1991 Mar; 49(3):330-41. PubMed ID: 1672513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs in the aetiology of agranulocytosis and aplastic anaemia.
    Kaufman DW; Kelly JP; Jurgelon JM; Anderson T; Issaragrisil S; Wiholm BE; Young NS; Leaverton P; Levy M; Shapiro S
    Eur J Haematol Suppl; 1996; 60():23-30. PubMed ID: 8987237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
    Maj S; Centkowski P
    Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: a report from the international agranulocytosis and aplastic anemia study.
    Levy M; Kelly JP; Kaufman DW; Shapiro S
    Ann Hematol; 1993 Oct; 67(4):187-90. PubMed ID: 8218540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress on the red cell diseases in China.
    Yue LZ; Shao ZH
    Chin Med J (Engl); 2012 Aug; 125(15):2746-51. PubMed ID: 22931985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.
    Rawson NS; Harding SR; Malcolm E; Lueck L
    J Clin Epidemiol; 1998 Dec; 51(12):1343-55. PubMed ID: 10086829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994.
    Wiholm BE; Emanuelsson S
    Eur J Haematol Suppl; 1996; 60():42-6. PubMed ID: 8987240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematological toxicity of ticlopidine.
    Lesesve JF; Callat MP; Lenormand B; Monconduit M; Noblet C; Moore N; Caron F; Humbert G; Stamatoullas A; Tilly H
    Am J Hematol; 1994 Oct; 47(2):149-50. PubMed ID: 8092140
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of aplastic anemia: a prospective multicenter study.
    Montané E; Ibáñez L; Vidal X; Ballarín E; Puig R; García N; Laporte JR;
    Haematologica; 2008 Apr; 93(4):518-23. PubMed ID: 18322256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group.
    Issaragrisil S; Sriratanasatavorn C; Piankijagum A; Vannasaeng S; Porapakkham Y; Leaverton PE; Kaufman DW; Anderson TE; Shapiro S; Young NS
    Blood; 1991 May; 77(10):2166-8. PubMed ID: 2029577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent idiopathic acute hepatitis-associated aplastic anemia/pancytopenia fourteen years after initial episode.
    Al Nahdi N; Wiesinger H; Sutherland H; Yoshida EM
    Ann Hepatol; 2010; 9(4):468-70. PubMed ID: 21057169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.